OrganOx Analysis: $238M Raised
What is OrganOx?
Normothermic perfusion technology for liver transplantation
Location
Oxford, United Kingdom
Employees
201-500
Founded
2008
Product Features & Capabilities
- metra® liver perfusion device
- Product documentation for metra®
- NMP technology for organ preservation
Use Cases
Utilize metra® for liver perfusion during transplantation; Conduct research on organ viability with NMP technology; Support air transport of livers with FDA-approved metra®; Enhance organ preservation for clinical trials; Decrease wait times for liver transplants
Other Considerations
Acquired by Terumo Corporation to advance organ transplantation; metra® received FDA approval for air transport; Collaborates with top institutions for organ research
Find more companies like OrganOx
See something that needs updating? Suggest edits to this profile.
